# RISK: __Enteric involvement in COVID-19 patients__ (PBN__Risk_292)

## Property: has_RiskGBN

* [No](PBN__RiskGBN_0)

## Property: has_RiskName

Increased severity, complications in diagnosis and treatment

## Property: has_RiskDescription

Evidence of gastrointestinal symptoms and enteric involvement in COVID-19 patients.

## Property: has_RiskTechnology

* [gastrointestinal monitoring tools](PBN__Technology_1001)
* [diagnostic tests](PBN__Technology_1002)

## Property: has_RiskType

* [health](PBN__RiskType_4)

## Property: has_RiskSubject

* [hospitalized covid-19 patients](PBN__Stakeholder_1091)

## Property: has_RiskMitigation

* [Attention to liver transplant recipients with metabolic comorbidities](PBN__RiskMitigation_365)
* [Monitor and manage gastrointestinal symptoms, enhance diagnostic capabilities](PBN__RiskMitigation_2215)

## Property: has_RiskSource

* [lodder_sars-cov-2_2020](PBN__Article_70)

## Property: has_RiskOwner

* [medical centers](PBN__Stakeholder_1092)
* [healthcare providers](PBN__Stakeholder_121)

## Property: has_RiskISO_Impact

* [Health and care](PBN__RiskISO_Purpose_0)

## Property: has_RiskISO_Purpose

* [Resilience](PBN__RiskISO_Impact_2)

## Property: has_RiskHealth

* [physical](PBN__RiskHealth_0)

